BCL-2 expression is mainly regulated by JAK/STAT3 pathway in human CD34+ hematopoietic cells

BCL-2 expression is mainly regulated by JAK/STAT3 pathway in human CD34 + hematopoietic cells

[1]  S. Akira,et al.  Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis , 2005, The Journal of experimental medicine.

[2]  Lesley J. Murray,et al.  Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone. , 1998, Blood.

[3]  F. Tresserra,et al.  Endometrial hyperplasia with secretory changes. , 2003, Gynecologic oncology.

[4]  B. Lord,et al.  CD34+AC133+ Cells Isolated from Cord Blood are Highly Enriched in Long‐Term Culture‐Initiating Cells, NOD/SCID‐Repopulating Cells and Dendritic Cell Progenitors , 1998, Stem cells.

[5]  C. Eaves,et al.  Overexpression of a dominant negative form of STAT3 selectively impairs hematopoietic stem cell activity , 2002, Oncogene.

[6]  Ulf R. Rapp,et al.  Apoptosis Suppression by Raf-1 and MEK1 Requires MEK- and Phosphatidylinositol 3-Kinase-Dependent Signals , 2001, Molecular and Cellular Biology.

[7]  A. Bernad,et al.  Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. , 1994, Immunity.

[8]  T. Hawley,et al.  Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. , 2002, Blood.

[9]  Giovanni Morrone,et al.  Constitutive Activation of STAT5A Promotes Human Hematopoietic Stem Cell Self-Renewal and Erythroid Differentiation , 2004, The Journal of experimental medicine.

[10]  J. Ihle,et al.  Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. , 2002, Blood.

[11]  B. Aggarwal,et al.  Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.

[12]  Huajun Yan,et al.  Interleukin-6 activates phosphoinositol-3′ kinase in multiple myeloma tumor cells by signaling through RAS-dependent and, separately, through p85-dependent pathways , 2004, Oncogene.

[13]  S. Rane,et al.  JAKs, STATs and Src kinases in hematopoiesis , 2002, Oncogene.